Revolab
Remote blood testing and health tracking platform.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor | €0.0 | round | |
€300k | Seed | ||
| Total Funding | 000k | ||
| EUR | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | 7 % | (67 %) |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Based in Vilnius, Lithuania, Revolab is a health technology firm operating a remote blood testing and tracking platform. The company was founded in 2020 by the husband-and-wife team Ovidijus Kalinas and Jekaterina Kaliniene. Kaliniene's role as the former CEO of Synlab Lithuania, a major European laboratory services company, provides a deep industry background that complements Kalinas's serial entrepreneurial experience.
Revolab's business model is centered on direct-to-consumer sales of at-home blood testing kits via its website and mobile application. The service allows individuals to monitor their health from home by collecting a small blood sample from their finger and sending it to a partner laboratory. The company promises lab-grade results within 24 hours, which are delivered through a personal digital account. These results are supplemented with insights from general practitioners to provide actionable health information. The company holds a medical license in Lithuania and its blood collection kit is CE-certified for 27 EU markets.
The product portfolio includes over 30 different tests, addressing a wide range of health concerns from thyroid function and sexually transmitted diseases to specific nutrient panels for vegans and vegetarians. A significant milestone for the company was securing a seed funding round of €300,000 in May 2021 from Kilo Health, another prominent Lithuanian health tech firm. This funding was earmarked for further product development, including enhancing its AI-powered test interpretation tools and creating a self-assessment feature to provide more comprehensive diagnostics. The company's services are also recognized and reimbursed by insurance partners like Gjensidige and Compensa Group.
Keywords: health technology, at-home blood testing, digital health, preventative healthcare, diagnostic services, remote diagnostics, personalized health, blood sample kit, health monitoring, medtech, Vilnius, Lithuania, direct-to-consumer healthcare, CE-certified medical device, AI health insights, lab testing, mobile health, wellness tracking, chronic disease monitoring